The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing

[SDV]Life Sciences [q-bio] Endocrinology, Diabetes and Metabolism Ovariectomy Bone architecture micro-CT AMP-Activated Protein Kinases histomorphometry Mice 03 medical and health sciences Bone Density 616 Animals Hypoglycemic Agents Femur Bony Callus Rats, Wistar Fracture Healing 0303 health sciences Tibia X-Ray Microtomography fracture healing Metformin Rats 3. Good health [SDV] Life Sciences [q-bio] Enzyme Activation Mice, Inbred C57BL Osteoporosis Original Article Female Bone Remodeling metformin Femoral Fractures
DOI: 10.1007/s00198-013-2371-0 Publication Date: 2013-05-03T10:38:02Z
ABSTRACT
The present study shows no adverse effects of the anti-diabetic drug metformin on bone mass and fracture healing in rodents but demonstrates that is not osteogenic vivo, as previously proposed. In view increased incidence fractures patients with type 2 diabetes mellitus (T2DM), we investigated metformin, a widely used T2DM therapy, vivo using two different rodent models modes administration. We first subjected 12-week-old female C57BL/6 mice to ovariectomy (OVX). Four weeks after OVX, received either saline or administered by gavage (100 mg/kg/daily). After 4 treatment, micro-architecture cellular activity were determined tibia micro-CT histomorphometry. another experiment, Wistar rats aged 3 months given only water for 8 via drinking (2 mg/ml). mid-diaphyseal osteotomy was performed left femur. Rats sacrificed architecture analysed right while callus volume femur X-ray analysis micro-CT, respectively. both models, our results show significant differences cortical trabecular metformin-treated compared saline. Metformin had effect resorption reduced formation rate bone. Mean scores assessed control showed between groups. Fracture mineral content similar Our indicate has rodents.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (77)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....